Serum concentrations and renal excretion in humans after oral administration of praziquantel — results of three determination methods —

1979 ◽  
Vol 4 (3) ◽  
pp. 149-156 ◽  
Author(s):  
K. Patzschke ◽  
J. Pütter ◽  
L. A. Wegner ◽  
F. A. Horster ◽  
H. W. Diekmann
1998 ◽  
Vol 39 (2) ◽  
pp. 373
Author(s):  
Kyung Myung Sohn ◽  
Oh Han Kwon ◽  
Sung Yong Lee ◽  
Jong Kwan Joo ◽  
Jae Hee Lee ◽  
...  

2021 ◽  
Vol 11 (1-s) ◽  
pp. 113-116
Author(s):  
Dhaval M Patel ◽  
Advaita B Patel ◽  
Bhumi R Patel ◽  
Deepa R Patel ◽  
Nishith K Patel

Evaluation of the efficacy of methanolic extract of Cucumis melo in urolithiasis induced by gentamycin and calculi producing diet on Wistar rats. Gentamycin (40 mg/kg, subcutaneously) and calculi-producing diet (CPD) was fed to induce urolithiasis on Wistar rats. The effect of oral administration of methanolic extract of Cucumis melo seed on calcium oxalate urolithiasis has been studied and is compared with the effect of oral administration of Cystone as standard on Wistar rats. Gentamycin and CPD feeding resulted in hyperoxaluria and calcium oxalate deposition as well as increased renal excretion of calcium and oxalate. Supplementation with methanolic extract of Cucumis melo seed reduced the elevated urinary oxalate, showing a regulatory action on endogenous oxalate synthesis. The results indicate that the seed of Cucumis melo is endowed with antiurolithiatic activity. Keywords: C. melo, Hyperoxaluria, calcium oxalate deposition, cystone, hyperoxaluria, analysis of variance


1958 ◽  
Vol 193 (2) ◽  
pp. 375-378 ◽  
Author(s):  
Richard T. Jones ◽  
William D. Blake

Several parameters related to the dynamics of distribution and renal excretion of epinephrine were studied in anesthetized dogs before and during oral administration of thyroid extract. These parameters include: a) plasma concentration and renal excretion of epinephrine during constant infusion of l-epinephrine bitartrate, b) the rate of disappearance from plasma and volume of distribution of epinephrine, and c) the resting excretion of endogenous epinephrine before and during thyroid feeding. Except for an increase in the percentage of infused epinephrine excreted in the urine, there were essentially no changes in these parameters after feeding thyroid.


1982 ◽  
Vol 5 (1-2) ◽  
pp. 47-52 ◽  
Author(s):  
Lawrence Grylack ◽  
Janet Boehnert ◽  
John Scanlon

1983 ◽  
Vol 81 (3) ◽  
pp. 289 ◽  
Author(s):  
L.M.L. Stolk ◽  
A.H. Siddiqui ◽  
R.H. Cormane

1990 ◽  
Vol 47 (4) ◽  
pp. 766-771 ◽  
Author(s):  
S. M. Plakas ◽  
R. W. Dickey ◽  
M. G. Barron ◽  
A. M. Guarino

Ormetoprim is used to potentiate sulfadimethoxine in treating certain bacterial diseases of aquatic species. The tissue disposition and renal excretion of ormetoprim and metabolites were examined after intravascular and oral administration (4 mg∙kg−1) in channel catfish (Ictalurus punctatus). Peak plasma level (0.66 μg∙mL−1) of 14C-ormetoprim occurred at 6 h after oral dosing. The oral bioavailability was estimated at 52%. Ormetoprim and metabolites were widely distributed in the tissues. The tissue concentrations were highest in the liver, trunk kidney, head kidney, and spleen. Clearance of the radiolabel from tissues was rapid. The muscle contained 49.3% of the intravascularly administered dose at 2 h; however, at 72 h, less than 1% of the dose remained in this tissue. 14C-Ormetoprim was more persistent in the skin than in the muscle. Ormetoprim was extensively metabolized in catfish. After intravascular administration, 21.1% of the dose of 14C-ormetoprim was eliminated in the urine in 48 h, predominantly as polar metabolites; less than 4% of the dose was eliminated as the parent compound. Biliary excretion was a minor route of elimination (5–6% of the dose). The data suggest branchial excretion of ormetoprim and/or metabolites.


1979 ◽  
Vol 82 (1) ◽  
pp. 149-157 ◽  
Author(s):  
YUKITAKA MIYACHI ◽  
HIDEKI YOTSUMOTO ◽  
TAKASHI KANO ◽  
AKIRA MIZUCHI ◽  
TETSUICHIRO MUTO ◽  
...  

SUMMARY Using reliable radioimmunoassay methods, the concentrations of prednisolone, prednisolone-hemisuccinate, betamethasone and betamethasone-17-benzoate were determined after administration by various routes. Serum prednisolone and betamethasone concentrations increased to peak levels 2 h after oral administration and then decreased gradually. The half-times of disappearance of prednisolone and betamethasone from blood, after a single oral dose, were both approximately 180–220 min. Five to fifteen minutes after intramuscular injections of 20 mg prednisolone-hemisuccinate the peak serum concentration was 63·7 ± 7·4 μg/ 100 ml and 30 min later plasma unesterified prednisolone reached its highest level (28·8 ± 2·6 μg/100 ml). The administration of steroids through the rectum induced gradual increases in the levels of serum steroids, reaching a maximum of 25% of the peak serum concentrations observed after oral administration. Plasma betamethasone-17-benzoate levels of 300 ng/ 100 ml were observed after topical application of betamethasone-17-benzoate gel to the skin. In patients with liver disease, the clearance of betamethasone was very slow compared with that in normal control subjects and significant amounts were retained in the blood 24 h after oral administration, showing that the liver is the most important organ for the metabolism of synthetic glucocorticoid. The concentrations of prednisolone and prednisolone-hemisuccinate in the cerebrospinal fluid were very low after the intramuscular injection of prednisolone-hemisuccinate, confirming the relative impermeability of the blood–brain barrier to polar steroids.


Sign in / Sign up

Export Citation Format

Share Document